# SGLT2 Inhibitors After Acute Kidney Injury With Indications Pilot

> **NCT06124924** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Minnesota** · enrollment: 1 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** SGLT2 inhibitor

## Key facts

- **NCT ID:** NCT06124924
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-04-01
- **Primary completion:** 2024-08-16
- **Final completion:** 2024-08-16
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2024-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06124924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06124924, "SGLT2 Inhibitors After Acute Kidney Injury With Indications Pilot". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06124924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*